Cargando…
Construction and characterization of a synthesized herpes simplex virus H129-Syn-G2
Herpes simplex virus type 1 (HSV-1) causes lifelong infections worldwide, and currently there is no efficient cure or vaccine. HSV-1-derived tools, such as neuronal circuit tracers and oncolytic viruses, have been used extensively; however, further genetic engineering of HSV-1 is hindered by its com...
Autores principales: | Xiao, Han, Hu, Hengrui, Guo, Yijia, Li, Jiang, Wen, Le, Zeng, Wen-Bo, Wang, Manli, Luo, Min-Hua, Hu, Zhihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311267/ https://www.ncbi.nlm.nih.gov/pubmed/36940800 http://dx.doi.org/10.1016/j.virs.2023.03.005 |
Ejemplares similares
-
Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain H129
por: Zeng, Wen-Bo, et al.
Publicado: (2017) -
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017) -
Treatment of human hepatocellular carcinoma by the oncolytic herpes simplex virus G47delta
por: Wang, Jiani, et al.
Publicado: (2014) -
Successful Rescue of Synthetic AcMNPV with a ~17 kb Deletion in the C1 Region of the Genome
por: Guo, Yijia, et al.
Publicado: (2022) -
Anti-tumor effect of oncolytic herpes simplex virus G47delta on human nasopharyngeal carcinoma
por: Wang, Jia-Ni, et al.
Publicado: (2011)